A preliminary report on the use of ceftizoxime vs. clindamycin/tobramycin for the therapy of intra-abdominal and pelvic infections.
D000005:Abdomen; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D001424:Bacterial Infections / Q000188:drug therapy* / Q000382:microbiology; D002439:Cefotaxime / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D015296:Ceftizoxime; D002981:Clindamycin / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D006801:Humans; D010388:Pelvis; D014031:Tobramycin / Q000627:therapeutic use*
D000900:Anti-Bacterial Agents; D002981:Clindamycin; D015296:Ceftizoxime; D002439:Cefotaxime; D014031:Tobramycin